Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endometrial Cancer Stage”

863 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 863 results

Early research (Phase 1)Study completedNCT02914470
What this trial is testing

Carboplatin-cyclophosphamide Combined With Atezolizumab

Who this might be right for
Breast CancerCervix CancerOvarian Cancer+1 more
The Netherlands Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT00502203
What this trial is testing

Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus

Who this might be right for
Mixed Tumor, Mullerian
M.D. Anderson Cancer Center 23
Large-scale testing (Phase 3)Looking for participantsNCT07166094
What this trial is testing

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

Who this might be right for
Endometrial CancerRecurrent or Progressive Endometrial Cancer
Genmab 660
Early research (Phase 1)Study completedNCT03629756
What this trial is testing

Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerSquamous Cell Carcinoma of the Head and NeckBreast Cancer+9 more
Arcus Biosciences, Inc. 48
Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Not applicableEnrolling By InvitationNCT06834204
What this trial is testing

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

Who this might be right for
CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Bladder Cancer+5 more
Rutgers, The State University of New Jersey 266
Early research (Phase 1)Active Not RecruitingNCT05238922
What this trial is testing

Study of INCB123667 in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Incyte Corporation 291
Early research (Phase 1)Active Not RecruitingNCT07038369
What this trial is testing

ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Who this might be right for
Advanced Solid TumorsBreast CancerBreast Carcinoma+24 more
Atavistik Bio, Inc 134
Testing effectiveness (Phase 2)Ended earlyNCT04030429
What this trial is testing

Crizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial Cancer

Who this might be right for
Endometrial Cancer Recurrent
National Cheng-Kung University Hospital 40
Very early researchNot Yet RecruitingNCT07812636
What this trial is testing

Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer

Who this might be right for
Grade 1 Endometrial Endometrioid CarcinomaEndometrial Intraepithelial NeoplasiaMetabolic Comorbidities
Milton S. Hershey Medical Center 15
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Testing effectiveness (Phase 2)Study completedNCT00006357
What this trial is testing

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 91
Testing effectiveness (Phase 2)Active Not RecruitingNCT03526432
What this trial is testing

Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer

Who this might be right for
Endometrial Cancer
University of Oklahoma 110
Testing effectiveness (Phase 2)Looking for participantsNCT06128551
What this trial is testing

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc. 534
Testing effectiveness (Phase 2)Ended earlyNCT02874430
What this trial is testing

Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer

Who this might be right for
Breast CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 29
Testing effectiveness (Phase 2)Looking for participantsNCT06040970
What this trial is testing

Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer

Who this might be right for
Ovarian CancerMalignant Neoplasm of Uterus
Icahn School of Medicine at Mount Sinai 54
Early research (Phase 1)Looking for participantsNCT05542407
What this trial is testing

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Who this might be right for
Endometrial CancerMetastasisEndometrioid Endometrial Cancer+5 more
UNC Lineberger Comprehensive Cancer Center 58
Early research (Phase 1)Ended earlyNCT05107739
What this trial is testing

DeTIL-0255 in Adults With Advanced Malignancies

Who this might be right for
Platinum-resistant Ovarian CancerEndometrial CancerCervical Cancer
Nurix Therapeutics, Inc. 5
Testing effectiveness (Phase 2)Study completedNCT00003127
What this trial is testing

S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer

Who this might be right for
Endometrial Cancer
SWOG Cancer Research Network 57
Testing effectiveness (Phase 2)Looking for participantsNCT06023862
What this trial is testing

A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+3 more
Yonsei University 198
Next Page